Prof. Volker Limmroth
ESSENTIALS Demenzerkrankungen: Das Wichtigste für Ärzte aller Fachrichtungen
Felbecker A, Limmroth V, Tettenborn B. ESSENTIALS Demenzerkrankungen: Das Wichtigste für Ärzte aller Fachrichtungen. München, Deutschland: Urban&Fischer/Elsevier, 2019. ISBN 978-3437212437.
01.01.2019ESSENTIALS Demenzerkrankungen: Das Wichtigste für Ärzte aller Fachrichtungen
01.01.2019Urban&Fischer/Elsevier, ISBN 978-3437212437
Felbecker Ansgar, Limmroth Volker, Tettenborn Barbara
Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
Putzki N, Baranwal M, Tettenborn B, Limmroth V, Kreuzfelder E. Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells. Eur Neurol 2010; 63:311-317.
05.05.2010Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
05.05.2010Eur Neurol 2010; 63:311-317
Putzki Norman, Baranwal Manoj Kumar, Tettenborn Barbara, Limmroth Volker, Kreuzfelder Ernst
Fatigue Is Not Associated with Impaired Function of Regulatory T Cells in Untreated Patients with Multiple Sclerosis
Yaldizli O, Kumar M, Vago S, Kreuzfelder E, Limmroth V, Putzki N. Fatigue Is Not Associated with Impaired Function of Regulatory T Cells in Untreated Patients with Multiple Sclerosis. European neurology 2009; 62:321-326.
10.09.2009Fatigue Is Not Associated with Impaired Function of Regulatory T Cells in Untreated Patients with Multiple Sclerosis
10.09.2009European neurology 2009; 62:321-326
Yaldizli Ozguer, Kumar Manoj, Vago Susanne, Kreuzfelder Erich, Limmroth Volker, Putzki Norman
Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study
Putzki N, Kumar M, Kreuzfelder E, Grosse-Wilde H, Diener H, Limmroth V. Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study. European neurology 2009; 61:27-32.
01.01.2009Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study
01.01.2009European neurology 2009; 61:27-32
Putzki Norman, Kumar Manoj, Kreuzfelder Ernst, Grosse-Wilde Hans, Diener H C, Limmroth Volker
Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients
Putzki N, Katsarava Z, Vago S, Diener H, Limmroth V. Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients. European neurology 2008; 59:136-42.
01.01.2008Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients
01.01.2008European neurology 2008; 59:136-42
Putzki Norman, Katsarava Zaza, Vago Susanne, Diener H C, Limmroth Volker
QUASIMS: eine deutschlandweite Beobachtungsstudie der Interferon-Beta-Präparate zur Therapie der schubförmigen multiplen Sklerose
Putzki N, Limmroth V. QUASIMS: eine deutschlandweite Beobachtungsstudie der Interferon-Beta-Präparate zur Therapie der schubförmigen multiplen Sklerose. Aktuelle Neurologie 2007; 01
11.01.2007QUASIMS: eine deutschlandweite Beobachtungsstudie der Interferon-Beta-Präparate zur Therapie der schubförmigen multiplen Sklerose
11.01.2007Aktuelle Neurologie 2007; 01
Putzki Norman, Limmroth Volker
Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis
Limmroth V, Wernsdörfer C, Kalski G, Putzki N, Hasford J, Brosig A, Meier U, Viehöver A, Obhof W, Elias W, Haller P, Japp G, Koehler J, Zettl U, Malessa R, QUASIMS Study Group. Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis. Journal of neurology 2007; 254:67-77.
01.01.2007Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis
01.01.2007Journal of neurology 2007; 254:67-77
Limmroth Volker, Wernsdörfer Colin, Kalski Gabriele, Putzki Norman, Hasford Joerg, Brosig Arne, Meier Uwe, Viehöver Andrea, Obhof Winfried, Elias Wolfgang, Haller Peter, Japp Gudrun, Koehler Jürgen, Zettl Uwe Klaus, Malessa Rolf, QUASIMS Study Group
CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis
Kumar M, Kreuzfelder E, Hardt C, Mueller N, Knop D, Lindemann M, Remus R, Limmroth V, Putzki N, Grosse-Wilde H. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. Journal of neuroimmunology 2006; 180:178-84.
01.11.2006CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis
01.11.2006Journal of neuroimmunology 2006; 180:178-84
Kumar Manoj, Kreuzfelder Ernst, Hardt Cornelia, Mueller Norbert, Knop Dietmar, Lindemann Monika, Remus Ralph, Limmroth Volker, Putzki Norman, Grosse-Wilde Hans
Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis
Putzki N, Knipp S, Ramczykowski T, Vago S, Germing U, Diener H, Limmroth V. Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 2006; 12:363-6.
01.06.2006Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis
01.06.2006Multiple sclerosis (Houndmills, Basingstoke, England) 2006; 12:363-6
Putzki Norman, Knipp Sabine, Ramczykowski Tim, Vago Susanne, Germing Ulrich, Diener H Chr, Limmroth Volker
High-dose, frequently administered interferon beta
Limmroth V, Putzki N. High-dose, frequently administered interferon beta. Journal of the neurological sciences 2005; 231:95-6; author reply 97-9.
15.04.2005High-dose, frequently administered interferon beta
15.04.2005Journal of the neurological sciences 2005; 231:95-6; author reply 97-9
Limmroth Volker, Putzki Norman